StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$35.57+0.65 (+1.86%)

Close on Nov 18, 2026Market cap $1.44BP/E 14.6Yield 1.35%

Phibro Animal Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Phibro Animal Health's operating cash flow for the twelve months ending Jun 30, 2026 was $68.95M, down 13.9% year over year. For fiscal 2026 it was $68.95M, down 13.9% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $98.39M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$68.95M-13.9%
FY2025Jun 30, 2025$80.12M-8.5%
FY2024Jun 30, 2024$87.59M+558.1%
FY2023Jun 30, 2023$13.31M-57.9%
FY2022Jun 30, 2022$31.65M-34.5%
FY2021Jun 30, 2021$48.31M-18.6%
FY2020Jun 30, 2020$59.35M+25.8%
FY2019Jun 30, 2019$47.17M-32.6%
FY2018Jun 30, 2018$70.01M-28.8%
FY2017Jun 30, 2017$98.39M+164.3%
FY2016Jun 30, 2016$37.22M-45.8%
FY2015Jun 30, 2015$68.70M–
FY2014Jun 30, 2014-$712.00K-149.5%
FY2013Jun 30, 2013$1.44M-95.5%
FY2012Jun 30, 2012$31.99M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$24.09M+13.3%
Q3 FY2026CQ1 2026Mar 31, 2026$16.21M-62.4%
Q2 FY2026CQ4 2025Dec 31, 2025$19.35M+529.1%
Q1 FY2026CQ3 2025Sep 30, 2025$9.30M-26.3%
Q4 FY2025CQ2 2025Jun 30, 2025$21.27M-25.2%
Q3 FY2025CQ1 2025Mar 31, 2025$43.15M+278.3%
Q2 FY2025CQ4 2024Dec 31, 2024$3.08M-90.3%
Q1 FY2025CQ3 2024Sep 30, 2024$12.62M-22.1%
Q4 FY2024CQ2 2024Jun 30, 2024$28.43M+40.5%
Q3 FY2024CQ1 2024Mar 31, 2024$11.41M+82.3%
Q2 FY2024CQ4 2023Dec 31, 2023$31.56M–
Q1 FY2024CQ3 2023Sep 30, 2023$16.20M–
Q4 FY2023CQ2 2023Jun 30, 2023$20.24M+1185.8%
Q3 FY2023CQ1 2023Mar 31, 2023$6.26M+2.1%
Q2 FY2023CQ4 2022Dec 31, 2022-$2.49M-112.4%
Q1 FY2023CQ3 2022Sep 30, 2022-$10.70M-380.0%
Q4 FY2022CQ2 2022Jun 30, 2022$1.57M-48.7%
Q3 FY2022CQ1 2022Mar 31, 2022$6.13M-63.1%
Q2 FY2022CQ4 2021Dec 31, 2021$20.12M-25.2%
Q1 FY2022CQ3 2021Sep 30, 2021$3.82M+125.0%
Q4 FY2021CQ2 2021Jun 30, 2021$3.07M-20.8%
Q3 FY2021CQ1 2021Mar 31, 2021$16.63M-38.3%
Q2 FY2021CQ4 2020Dec 31, 2020$26.91M-16.1%
Q1 FY2021CQ3 2020Sep 30, 2020$1.70M–
Q4 FY2020CQ2 2020Jun 30, 2020$3.88M-73.9%
Q3 FY2020CQ1 2020Mar 31, 2020$26.95M+72.2%
Q2 FY2020CQ4 2019Dec 31, 2019$32.09M+109.0%
Q1 FY2020CQ3 2019Sep 30, 2019-$3.57M-378.9%
Q4 FY2019CQ2 2019Jun 30, 2019$14.88M+47.2%
Q3 FY2019CQ1 2019Mar 31, 2019$15.65M-31.4%
Q2 FY2019CQ4 2018Dec 31, 2018$15.36M-52.4%
Q1 FY2019CQ3 2018Sep 30, 2018$1.28M-73.3%
Q4 FY2018CQ2 2018Jun 30, 2018$10.11M-25.5%
Q3 FY2018CQ1 2018Mar 31, 2018$22.81M-38.5%
Q2 FY2018CQ4 2017Dec 31, 2017$32.29M+22.9%
Q1 FY2018CQ3 2017Sep 30, 2017$4.80M-77.6%
Q4 FY2017CQ2 2017Jun 30, 2017$13.58M–
Q3 FY2017CQ1 2017Mar 31, 2017$37.08M–
Q2 FY2017CQ4 2016Dec 31, 2016$26.28M–
Q1 FY2017CQ3 2016Sep 30, 2016$21.46M–

More Phibro Animal Health figures

See a number that looks wrong?